课题基金 / 基金详情

PHASE III CLINICAL STUDY OF HYPERIMMUNE ANTI HIVIG PREVENTION OF AIDS IN INFANTS

PHASE III CLINICAL STUDY OF HYPERIMMUNE ANTI HIVIG PREVENTION OF AIDS IN INFANTS
超免疫抗HIVIG预防婴儿艾滋病的III期临床研究
批准号：
6117108
负责人：
MARGARET A KELLER
金额：
$3.89万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6117108
关键词：
AIDS therapy HIV infections chemoprevention clinical research combination chemotherapy congenital infection disease /disorder prevention /control female human pregnant subject human therapy evaluation immunoglobulins immunotherapy intravenous administration microorganism disease chemotherapy outcomes research pediatric AIDS pregnancy infection vertical transmission zidovudine

项目摘要

项目成果

MARGARET A KELLER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To determine if giving HIVIG to pregnant HIV infected women taking AZT can lower the chance for their babies to get HIV from their mothers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL DRUG COMBINATIONS HIV
INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL DRUG COMBINATIONS
Two-Dimensional 3 Tesla MRS of the Brain in HIV- Infected Youth
PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL THERAPY DURING PREGNANCY
海外基金